Hält derzeit eine Position bei Bloom Energy Corp
Position | Company | Period |
---|---|---|
Independent Director | Bloom Energy Corp | 1. Januar 2003 - |
Lead Independent Director | Tableau Software LLC | None - |
Independent Director | Workday Inc | 1. Juli 2009 - 3. Juni 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-24 | 2024-04-22 |
Frequency Therapeutics Inc
(FREQ)
|
K Kauf |
17.857
+1.7%
56,00999.992 USD |
17.857 +1.7% | 56,00 | 999.992 USD | |
2023-11-22 | 2023-11-20 |
Cloudflare Inc
(NET)
|
GV Geplanter Verkauf |
78.389
-69.4%
73,025.723.965 USD |
78.389 -69.4% | 73,02 | 5.723.965 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
V Verkauf |
6.570
-100.0%
66,57437.335 USD |
6.570 -100.0% | 66,57 | 437.335 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
V Verkauf |
2.944
-30.9%
65,30192.254 USD |
2.944 -30.9% | 65,30 | 192.254 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
V Verkauf |
9.455
-49.8%
64,54610.194 USD |
9.455 -49.8% | 64,54 | 610.194 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
V Verkauf |
1.338
-6.6%
63,8185.374 USD |
1.338 -6.6% | 63,81 | 85.374 USD | |
2023-07-19 | 2023-07-17 |
Savara Inc
(SVRA)
|
K Kauf |
333.333
+1.4%
3,00999.999 USD |
333.333 +1.4% | 3,00 | 999.999 USD | |
2023-01-27 | 2023-01-26 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
1.351.092
-37.7%
3,124.213.786 USD |
1.351.092 -37.7% | 3,12 | 4.213.786 USD | |
2023-01-27 | 2023-01-26 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
1.648.908
-37.7%
3,125.142.614 USD |
1.648.908 -37.7% | 3,12 | 5.142.614 USD | |
2023-01-27 | 2023-01-25 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
293.645
-7.6%
3,26958.428 USD |
293.645 -7.6% | 3,26 | 958.428 USD | |
2023-01-27 | 2023-01-25 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
358.371
-7.6%
3,261.169.687 USD |
358.371 -7.6% | 3,26 | 1.169.687 USD | |
2023-01-06 | 2023-01-05 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
32.139
-0.8%
2,7688.659 USD |
32.139 -0.8% | 2,76 | 88.659 USD | |
2023-01-06 | 2023-01-05 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
39.223
-0.8%
2,76108.201 USD |
39.223 -0.8% | 2,76 | 108.201 USD | |
2023-01-04 | 2023-01-04 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
45.930
-1.2%
2,91133.643 USD |
45.930 -1.2% | 2,91 | 133.643 USD | |
2023-01-04 | 2023-01-04 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
56.054
-1.2%
2,91163.100 USD |
56.054 -1.2% | 2,91 | 163.100 USD | |
2023-01-04 | 2023-01-03 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
78.730
-1.9%
2,99235.411 USD |
78.730 -1.9% | 2,99 | 235.411 USD | |
2023-01-04 | 2023-01-03 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
96.084
-1.9%
2,99287.301 USD |
96.084 -1.9% | 2,99 | 287.301 USD | |
2023-01-04 | 2022-12-30 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
54.645
-1.3%
3,02165.028 USD |
54.645 -1.3% | 3,02 | 165.028 USD | |
2023-01-04 | 2022-12-30 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
66.690
-1.3%
3,02201.404 USD |
66.690 -1.3% | 3,02 | 201.404 USD | |
2022-12-27 | 2022-12-23 |
Arcellx Inc
(ACLX)
|
V Verkauf |
195
-100.0%
31,676.176 USD |
195 -100.0% | 31,67 | 6.176 USD | |
2022-12-27 | 2022-12-23 |
Arcellx Inc
(ACLX)
|
V Verkauf |
195
-100.0%
31,676.176 USD |
195 -100.0% | 31,67 | 6.176 USD | |
2022-12-22 | 2022-12-21 |
Arcellx Inc
(ACLX)
|
V Verkauf |
179
-100.0%
30,745.502 USD |
179 -100.0% | 30,74 | 5.502 USD | |
2022-05-26 | 2022-05-25 |
Genocea Biosciences Inc
(GNCA)
|
V Verkauf |
4.445.093
-100.0%
0,08362.720 USD |
4.445.093 -100.0% | 0,08 | 362.720 USD | |
2022-05-26 | 2022-05-24 |
Genocea Biosciences Inc
(GNCA)
|
V Verkauf |
5.931.843
-57.2%
0,07387.943 USD |
5.931.843 -57.2% | 0,07 | 387.943 USD | |
2022-05-16 | 2022-05-12 |
Robinhood Markets Inc
(HOOD)
|
V Verkauf |
4.396
-100.0%
8,4136.970 USD |
4.396 -100.0% | 8,41 | 36.970 USD | |
2022-05-16 | 2022-05-12 |
Robinhood Markets Inc
(HOOD)
|
V Verkauf |
4.396
-100.0%
8,4136.970 USD |
4.396 -100.0% | 8,41 | 36.970 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
948.948
+inf%
1,901.803.001 USD |
948.948 +inf% | 1,90 | 1.803.001 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
2.631.578
+33.8%
1,904.999.998 USD |
2.631.578 +33.8% | 1,90 | 4.999.998 USD | |
2021-10-19 | 2021-10-18 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
1.851.852
0,000 USD |
1.851.852 | 0,00 | 0 USD | |
2021-03-18 | 2021-03-16 |
Marker Therapeutics Inc
(MRKR)
|
K Kauf |
5.714.285
+114.3%
1,759.999.999 USD |
5.714.285 +114.3% | 1,75 | 9.999.999 USD | |
2020-06-22 | 2020-06-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
1.428.571
+56.6%
5,257.499.998 USD |
1.428.571 +56.6% | 5,25 | 7.499.998 USD | |
2019-04-08 | 2019-04-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
4.347.827
+20.8%
1,144.956.523 USD |
4.347.827 +20.8% | 1,14 | 4.956.523 USD | |
2018-12-21 | 2018-12-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
300.000
+1.5%
1,49448.380 USD |
300.000 +1.5% | 1,49 | 448.380 USD | |
2018-12-21 | 2018-12-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
200.000
+1.0%
1,63326.060 USD |
200.000 +1.0% | 1,63 | 326.060 USD | |
2018-12-12 | 2018-12-11 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
61.200
+0.3%
1,98121.084 USD |
61.200 +0.3% | 1,98 | 121.084 USD | |
2018-12-10 | 2018-12-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
26.000
+0.1%
1,9851.576 USD |
26.000 +0.1% | 1,98 | 51.576 USD | |
2018-12-10 | 2018-12-07 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
117.100
+0.6%
1,98232.362 USD |
117.100 +0.6% | 1,98 | 232.362 USD | |
2018-12-10 | 2018-12-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
27.300
+0.1%
1,9954.414 USD |
27.300 +0.1% | 1,99 | 54.414 USD | |
2018-11-30 | 2018-11-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
71.900
+0.4%
1,98142.067 USD |
71.900 +0.4% | 1,98 | 142.067 USD | |
2018-11-30 | 2018-11-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
24.500
+0.1%
1,9948.824 USD |
24.500 +0.1% | 1,99 | 48.824 USD | |
2018-11-21 | 2018-11-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
170.000
+0.9%
1,98336.107 USD |
170.000 +0.9% | 1,98 | 336.107 USD | |
2018-11-19 | 2018-11-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
510.000
+2.6%
1,88956.658 USD |
510.000 +2.6% | 1,88 | 956.658 USD | |
2018-11-19 | 2018-11-16 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
350.000
+1.8%
1,86649.355 USD |
350.000 +1.8% | 1,86 | 649.355 USD | |
2018-11-19 | 2018-11-15 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
340.000
+1.8%
1,86631.958 USD |
340.000 +1.8% | 1,86 | 631.958 USD | |
2018-08-22 | 2018-08-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
663.716
+3.7%
2,261.499.998 USD |
663.716 +3.7% | 2,26 | 1.499.998 USD | |
2018-07-20 | 2018-07-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
50.600
+0.3%
2,00101.165 USD |
50.600 +0.3% | 2,00 | 101.165 USD | |
2018-07-20 | 2018-07-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
200.000
+1.1%
1,95390.580 USD |
200.000 +1.1% | 1,95 | 390.580 USD | |
2018-06-28 | 2018-06-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
187.130
+1.1%
2,10392.692 USD |
187.130 +1.1% | 2,10 | 392.692 USD | |
2018-06-28 | 2018-06-27 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
5.295
+0.0%
2,1511.384 USD |
5.295 +0.0% | 2,15 | 11.384 USD | |
2018-05-30 | 2018-05-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
275
+0.0%
2,15591 USD |
275 +0.0% | 2,15 | 591 USD | |
2018-05-21 | 2018-05-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
32.200
+0.2%
2,1469.059 USD |
32.200 +0.2% | 2,14 | 69.059 USD | |
2018-05-21 | 2018-05-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
20.100
+0.1%
2,1442.928 USD |
20.100 +0.1% | 2,14 | 42.928 USD | |
2018-05-21 | 2018-05-17 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
184.179
+1.1%
2,13391.436 USD |
184.179 +1.1% | 2,13 | 391.436 USD | |
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
5.533
-0.1%
17,8198.543 USD |
5.533 -0.1% | 17,81 | 98.543 USD | |
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
4.006
-0.1%
17,8171.347 USD |
4.006 -0.1% | 17,81 | 71.347 USD | |
2018-05-10 | 2018-05-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
70.873
+0.4%
2,13151.250 USD |
70.873 +0.4% | 2,13 | 151.250 USD | |
2018-04-10 | 2018-04-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
203.200
+1.2%
2,46499.994 USD |
203.200 +1.2% | 2,46 | 499.994 USD | |
2018-04-10 | 2018-04-09 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
32.100
+0.2%
2,4378.099 USD |
32.100 +0.2% | 2,43 | 78.099 USD | |
2018-04-10 | 2018-04-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
685.676
+4.2%
2,241.536.943 USD |
685.676 +4.2% | 2,24 | 1.536.943 USD | |
2017-03-29 | 2017-03-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
6.000.000
+57.9%
0,503.000.000 USD |
6.000.000 +57.9% | 0,50 | 3.000.000 USD | |
2015-11-18 | 2015-11-16 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
452
-0.0%
6,913.123 USD |
452 -0.0% | 6,91 | 3.123 USD | |
2014-08-29 | 2014-08-29 |
Sunesis Pharmaceuticals Inc
(SNSS)
|
V Verkauf |
11.600
-0.2%
7,5187.070 USD |
11.600 -0.2% | 7,51 | 87.070 USD | |
2014-08-12 | 2014-08-12 |
Sunesis Pharmaceuticals Inc
(SNSS)
|
V Verkauf |
35.540
-0.7%
6,76240.190 USD |
35.540 -0.7% | 6,76 | 240.190 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
512.500
+14.3%
8,004.100.000 USD |
512.500 +14.3% | 8,00 | 4.100.000 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
487.500
+12.2%
8,003.900.000 USD |
487.500 +12.2% | 8,00 | 3.900.000 USD | |
2004-10-01 | 2004-09-29 |
Gilead Colorado Inc
(MYOG)
|
K Kauf |
858.235
+25.7%
6,505.578.528 USD |
858.235 +25.7% | 6,50 | 5.578.528 USD |